D
David G. Fernig
Researcher at University of Liverpool
Publications - 237
Citations - 14217
David G. Fernig is an academic researcher from University of Liverpool. The author has contributed to research in topics: Fibroblast growth factor & Heparan sulfate. The author has an hindex of 56, co-authored 229 publications receiving 12879 citations. Previous affiliations of David G. Fernig include Royal Liverpool University Hospital & University of Bologna.
Papers
More filters
Journal ArticleDOI
Determination of size and concentration of gold nanoparticles from UV-vis spectra
TL;DR: It is shown that the data produced here can be used to determine both size and concentration of gold nanoparticles directly from UV-vis spectra, and the precision of various methods are discussed.
Journal ArticleDOI
Rational and Combinatorial Design of Peptide Capping Ligands for Gold Nanoparticles
Raphaël Lévy,Nguyen T. K. Thanh,R. C. Doty,Irshad Hussain,Richard J. Nichols,David J. Schiffrin,Mathias Brust,David G. Fernig +7 more
TL;DR: Based on protein folding considerations, a pentapeptide ligand, CALNN, which converts citrate-stabilized gold nanoparticles into extremely stable, water-solublegold nanoparticles with some chemical properties analogous to those of proteins, has been designed.
Journal ArticleDOI
A rapid method to estimate the concentration of citrate capped silver nanoparticles from UV-visible light spectra
TL;DR: A generalized table of extinction coefficient data for silver nanoparticles from 8 to 100 nm is presented, in good agreement with collated literature values measured by different authors with non-standardized methodology and each for a limited range of particle size.
Journal ArticleDOI
Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate.
TL;DR: The data indicate a primary role for contiguous sequences of IdoA(2-OSO3)alpha 1,4GlcNSO3 in mediating the high affinity binding between fibroblast HS and bFGF.
Journal ArticleDOI
Kinase-Catalyzed Modification of Gold Nanoparticles: A New Approach to Colorimetric Kinase Activity Screening
TL;DR: A simple colorimetric test to monitor kinase inhibitor activity is developed based on enzymatically biotinylated gold nanoparticles that change color from red to blue, indicating aggregation of particles.